BTG4 Human Pre-designed siRNA Set A contains three designed siRNAs for BTG4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BTK degrader-1 (compound 1) is a Bruton’s tyrosine kinase (BTK) bifunctional degrader that can be conjugated with CD79b. BTK degrader-1 (compound 1) has anti-tumor effect[1].

BTK Human Pre-designed siRNA Set A contains three designed siRNAs for BTK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Btk Mouse Pre-designed siRNA Set A contains three designed siRNAs for Btk gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Btk Rat Pre-designed siRNA Set A contains three designed siRNAs for Btk gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

BTK-IN-34 (compound 9h) is a selective BTK inhibitor. BTK-IN-34 shows antiproliferative activity in RAMOS cells through selective inhibition of pBTK (Tyr223) without affecting Lyn and Syk, upstream proteins in the BCR signaling pathway[1].

BTL-MK (Compound 19) an orally active antiallergic agent, that inhibits degranulation of mast cells with an IC50 of 6.7 μM, through binding to the inhibitory receptor FcγRIIB. BTL-MK improves the metaboilic stability in human liver microsomes. BTL-MK ameliorates the allergic response in Ovalbumin (HY-W250978)-induced food allergy mice model. BTL-MK exhibits a good pharmacokinetic character with […]

BTLA Human Pre-designed siRNA Set A contains three designed siRNAs for BTLA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BTN1A1 Human Pre-designed siRNA Set A contains three designed siRNAs for BTN1A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BTN2A1 Human Pre-designed siRNA Set A contains three designed siRNAs for BTN2A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BTN2A2 Human Pre-designed siRNA Set A contains three designed siRNAs for BTN2A2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BTN3A1 Human Pre-designed siRNA Set A contains three designed siRNAs for BTN3A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BTN3A2 Human Pre-designed siRNA Set A contains three designed siRNAs for BTN3A2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BTN3A3 Human Pre-designed siRNA Set A contains three designed siRNAs for BTN3A3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BTNL2 Human Pre-designed siRNA Set A contains three designed siRNAs for BTNL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BTNL3 Human Pre-designed siRNA Set A contains three designed siRNAs for BTNL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BTNL8 Human Pre-designed siRNA Set A contains three designed siRNAs for BTNL8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BTNL9 Human Pre-designed siRNA Set A contains three designed siRNAs for BTNL9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BTRC Human Pre-designed siRNA Set A contains three designed siRNAs for BTRC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BTX-6654 is a target-dependent and -specific cereblon-based bifunctional SOS1 PROTAC degrader. BTX-6654 reduces downstream signaling markers pERK and pS6, and displays antiproliferative activity in cells harboring various KRAS mutations[1].

BUB1 Human Pre-designed siRNA Set A contains three designed siRNAs for BUB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BUB1B Human Pre-designed siRNA Set A contains three designed siRNAs for BUB1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BUB3 Human Pre-designed siRNA Set A contains three designed siRNAs for BUB3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BuChE-IN-10 (compound 7p) is an inhibitor of BuChE (eqBuChE IC50 = 4.68 nM, huBuChE IC50 = 9.12 nM). BuChE-IN-10 has anti-neuroinflammatory activity and exhibits high BBB permeability[1].

BUD13 Human Pre-designed siRNA Set A contains three designed siRNAs for BUD13 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BUD23 Human Pre-designed siRNA Set A contains three designed siRNAs for BUD23 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BUD31 Human Pre-designed siRNA Set A contains three designed siRNAs for BUD31 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Bumetanide (Standard) is the analytical standard of Bumetanide. This product is intended for research and analytical applications. Bumetanide (Ro 10-6338; PF 1593), a highly potent loop diuretic, is a Na+-K+-Cl+ cotransporter (NKCC) blocker. Bumetanide is a selective NKCC1 inhibitor, but also inhibits NKCC2, with IC50s of 0.68 μM and 4.0 μM for hNKCC1A and hNKCC2A, […]

BUR1 is a BMP upregulator (EC50: 98 nM) and activates BMPRII signalling. BUR1 induces BMP2 and PTGS2 expression. BUR1 reversed pulmonary arterial pressure in Monocrotaline (HY-N0750) induced rats[1].

Butylated hydroxytoluene (Standard) is the analytical standard of Butylated hydroxytoluene. This product is intended for research and analytical applications. Butylated hydroxytoluene is an antioxidant widely used in foods and in food-related products[1]. Butylated hydroxytoluene is a Ferroptosis inhibitor[2].

Butylated hydroxytoluene (Standard) is the analytical standard of Butylated hydroxytoluene. This product is intended for research and analytical applications. Butylated hydroxytoluene is an antioxidant widely used in foods and in food-related products[1]. Butylated hydroxytoluene is a Ferroptosis inhibitor[2].

Butylated hydroxytoluene (Standard) is the analytical standard of Butylated hydroxytoluene. This product is intended for research and analytical applications. Butylated hydroxytoluene is an antioxidant widely used in foods and in food-related products[1]. Butylated hydroxytoluene is a Ferroptosis inhibitor[2].

Butylated hydroxytoluene (Standard) is the analytical standard of Butylated hydroxytoluene. This product is intended for research and analytical applications. Butylated hydroxytoluene is an antioxidant widely used in foods and in food-related products[1]. Butylated hydroxytoluene is a Ferroptosis inhibitor[2].

Butylhydroxyanisole (Standard) is the analytical standard of Butylhydroxyanisole. This product is intended for research and analytical applications. Butylhydroxyanisole (Butylated hydroxyanisole) is an antioxidant used as a food additive preservative. Butylhydroxyanisole mediates liver toxicity, retardation in reproductive organ development and learning, and sleep deficit. Butylhydroxyanisole exerts neurotoxic effects and leads to disruption of the brain and […]

Butyne-DOTAis a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DOTA derivative used for tumor pre-targeting. Butyne-DOTA can be used for conjugation of peptides and radionuclides.

Butyne-DOTA-tris(t-butyl ester)is a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DOTA derivative used for tumor pre-targeting. Butyne-DOTA-tris(t-butyl ester) can be used for conjugation of peptides and radionuclides.

Butyramide is a biochemical reagent that can be used as a biological material or organic compound for life science related research[1].

Butyryl-Coenzyme A (trisodium) can synthesize Butyric acid (HY-B0350) or Butyrate[1][2].

BVES Human Pre-designed siRNA Set A contains three designed siRNAs for BVES gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BWX 46 (((Cys31, Nva 34)-Neuropeptide Y (27-36))2) is a selective Y5 receptor agonist with an IC50 value of 0.85 nM. BWX 46 can inhibit the synthesis of cAMP in Y5 cells[1].

BYSL Human Pre-designed siRNA Set A contains three designed siRNAs for BYSL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Bz-DTPA (hydrochloride)is a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DPTA derivative used for tumor pre-targeting. Bz-DTPA (hydrochloride) can be used for conjugation of peptides and radionuclides.

BZG2 is an allosteric inhibitor for the SARS-CoV-2 main protease (Mpro), with an IC50 of 77 µM[1].

BZW1 Human Pre-designed siRNA Set A contains three designed siRNAs for BZW1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.